Preextinction Viral RNA Can Interfere with Infectivity

Journal of Virology

Volumn 78, Issue 7, 2004, Pages 3319-3324

  González López, Claudia ^a   Arias, Armando ^a   Pariente, Nonia ^a   Gómez Mariano, Gema ^a   Domingo, Esteban ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; FOOT AND MOUTH DISEASE VIRUS; GENETIC TRANSFECTION; HOST CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS SURVIVAL; ANIMAL; CELL LINE; DEFECTIVE VIRUS; ELECTROPORATION; GENETICS; HAMSTER; KINETICS; METABOLISM; MUTATION; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; CELL LINE; CRICETINAE; DEFECTIVE VIRUSES; ELECTROPORATION; FOOT-AND-MOUTH DISEASE VIRUS; KINETICS; MUTAGENESIS; MUTATION; RNA, VIRAL; VIRUS REPLICATION;

EID: 1842510032     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.7.3319-3324.2004     Document Type: Article

References (53)

1. Airaksinen, A., N. Pariente, L. Menendez-Arias, and E. Domingo. 2003. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311:339-349.
2. Alves, D., and J. F. Fontanari. 1998. Error threshold in finite populations. Phys. Rev. E 57:7008-7013.
3. Arias, A., E. Lázaro, C. Escarmís, and E. Domingo. 2001. Molecular intermediates of fitness gain of an RNA virus: characterization of a mutant spectrum by biological and molecular cloning. J. Gen. Virol. 82:1049-1060.
4. Baranowski, E., C. M. Ruíz-Jarabo, N. Pariente, N. Verdaguer, and E. Domingo. 2003. Evolution of cell recognition by viruses: a source of biological novelty with medical implications. Adv. Virus Res. 62:19-111.
5. Baranowski, E., N. Sevilla, N. Verdaguer, C. M. Ruíz-Jarabo, E. Beck, and E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362-6372.
6. Belsham, G. J. 1993. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol. 60:241-260.
7. Borman, A. M., S. Paulous, and F. Clavel. 1996. Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. J. Gen. Virol. 77:419-426.
8. Cases-González, C. E., and L. Menéndez-Arias. 2004. Increased G→A transition frequencies displayed by primer grip mutants of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 78:1012-1019.
9. Charpentier, N., M. Dávila, E. Domingo, and C. Escarmís. 1996. Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223:10-18.
10. Chumakov, K. M., L. B. Powers, K. E. Noonan, I. B. Roninson, and I. S. Levenbook. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA 88:199-203.
11. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.). 2003. Measurement of antiviral activity induced by interferons α, β, and γ. Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
12. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:6895-6900.
13. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. N. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat. Med. 6:1375-1379.
14. de la Torre, J. C., and J. J. Holland. 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:6278-6281.
15. Domingo, E. 1989. RNA virus evolution and the control of viral disease. Prog. Drug Res. 33:93-133.
16. Domingo, E. 2000. Viruses at the edge of adaptation. Virology 270:251-253.
17. Domingo, E., C. Biebricher, M. Eigen, and J. J. Holland. 2001. Quasispecies and RNA virus evolution: principles and consequences. Landes Bioscience, Austin, Tex.
18. Domingo, E., M. Dávila, and J. Ortín. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11:333-346.
19. Domingo, E., and J. J. Holland. 1992. Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents. Genet. Eng. 14:13-31.
20. Domingo, E., A. Mas, E. Yuste, N. Pariente, S. Sierra, M. Gutiérrez-Riva, and L. Menéndez-Arias. 2001. Virus population dynamics, fitness variations and the control of viral disease: an update. Prog. Drug Res. 57:77-115.
21. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13913.
22. Eigen, M. 2002. Error catastrophe and antiviral strategy. Proc. Natl. Acad. Sci. USA 99:13374-13376.
23. Eigen, M., and C. K. Biebricher. 1988. Sequence space and quasispecies distribution, p. 211-245. In E. Domingo, P. Ahlquist, and J. J. Holland (ed.), RNA genetics, vol. 3. CRC Press, Boca Raton, Fla.
24. Escarmís, C., M. Dávila, and E. Domingo. 1999. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285:495-505.
25. Flint, S. J., L. W. Enquist, V. R. Racaniello, and A. M. Skalka. 2004. Principles of virology: molecular biology, pathogenesis, and control of animal viruses. ASM Press, Washington, D.C.
26. Graci, J. D., and C. E. Cameron. 2002. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 298:175-180.
27. Grande-Pérez, A., S. Sierra, M. G. Castro, E. Domingo, and P. R. Lowenstein. 2002. Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl. Acad. Sci. USA 99:12938-12943.
28. Ho, D. D. 1995. Time to hit HIV, early and hard. N. Engl. J. Med. 333:450-451.
29. Holland, J. J., E. Domingo, J. C. de la Torre, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:3960-3962.
30. Hunziker, L., A. Ciurea, M. Recher, H. Hengartner, and R. M. Zinkernagel. 2003. Public versus personal serotypes of a viral quasispecies. Proc. Natl. Acad. Sci. USA 100:.6015-6020.
31. Lanford, R. E., D. Chavez, B. Guerra, J. Y. Lau, Z. Hong, K. M. Brasky, and B. Beames. 2001. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J. Virol. 75:8074-8081.
32. Loeb, L. A., J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins. 1999. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. USA 96:1492-1497.
33. Loeb, L. A., and J. I. Mullins. 2000. Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res. Hum. Retrovir. 13:1-3.
34. Maag, D., C. Castro, Z. Hong, and C. E. Cameron. 2001. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J. Biol. Chem. 276:46094-46098.
35. Menéndez-Arias, L. 2002. Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol. Sci. 23:381-388.
36. Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher. 1999. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13:2349-2359.
37. Nowak, M., and P. Schuster. 1989. Error thresholds of replication in finite populations, mutation frequencies and the onset of Muller's ratchet. J. Theor. Biol. 137:375-395.
38. Pariente, N., A. Airaksinen, and E. Domingo. 2003. Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol. 77:7131-7138.
39. Pariente, N., S. Sierra, P. R. Lowenstein, and E. Domingo. 2001. Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol. 75:9723-9730.
40. Pfeiffer, J. K., and K. Kirkegaard. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. USA 100:7289-7294.
41. Richman, D. D. (ed.). 1996. Antiviral drug resistance. John Wiley & Sons, Inc., New York, N.Y.
42. Ruíz-Jarabo, C. M., C. Ly, E. Domingo, and J. C. de la Torre. 2003. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37-47.
43. Severson, W. E., C. S. Schmaljohn, A. Javadian, and C. B. Jonsson. 2003. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 77:481-488.
44. Sierra, S., M. Dávila, P. R. Lowenstein, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323.
45. Sobrino, F., M. Dávila, J. Ortín, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310-318.
46. Swetina, J., and P. Schuster. 1982. Self-replication with errors. A model for polynucleotide replication. Biophys. Chem. 16:329-345.
47. Taboga, O., C. Tami, E. Carrillo, J. I. Núñez, A. Rodríguez, J. C. Saíz, E. Blanco, M. L. Valero, X. Roig, J. A. Camarero, D. Andreu, M. G. Mateu, E. Giralt, E. Domingo, F. Sobrino, and E. L. Palma. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606-2614.
48. Tami, C., O. Taboga, A. Berinstein, J. I. Nuñez, E. L. Palma, E. Domingo, F. Sobrino, and E. Carrillo. 2003. Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J. Virol. 77:1219-1226.
49. Teng, M. N., M. B. Oldstone, and J. C. de la Torre. 1996. Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. Virology 223:113-119.
50. Toja, M. 1997. Caracterización molecular de un virus de la fiebre aftosa y de sus derivados persistentes. Construcción de un clon infeccioso. Ph.D. thesis. Universidad Autónoma de Madrid, Madrid, Spain.
51. Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40:9-17.
52. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755-2759.
53. Young, K. C., K. L. Lindsay, K. J. Lee, W. C. Liu, J. W. He, S. L. Milstein, and M. M. Lai. 2003. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology 38:869-878.